Home Cart Sign in  
Chemical Structure| 326914-06-1 Chemical Structure| 326914-06-1

Structure of MHY1485
CAS No.: 326914-06-1

Chemical Structure| 326914-06-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

MHY1485 is a potent, cell-permeable mTOR activator that targets the ATP domain of mTOR and inhibits autophagy by suppressing the fusion between autophagosomes and lysosomes.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of MHY1485

CAS No. :326914-06-1
Formula : C17H21N7O4
M.W : 387.39
SMILES Code : O=[N+](C1=CC=C(NC2=NC(N3CCOCC3)=NC(N4CCOCC4)=N2)C=C1)[O-]
MDL No. :MFCD00489974
InChI Key :MSSXBKQZZINCRI-UHFFFAOYSA-N
Pubchem ID :2834965

Safety of MHY1485

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of MHY1485

PI3K-AKT

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
U87 25 μM 5 days MHY1485 failed to effectively inhibit autophagy, explaining its failure to have synergistic effect with chemotherapies PMC5833690
U251 25 μM 5 days MHY1485 failed to effectively inhibit autophagy, explaining its failure to have synergistic effect with chemotherapies PMC5833690
NIH3T3 cells 10 nM MHY1485, as a chemical activator of mTORC1, erased the decline of p16 protein abundance in senescent cells caused by miR-708 overexpression. PMC10924637
HCT116 cells 2 μM MHY1485 was used as an autophagy inhibitor to study the role of FAT4 in autophagy regulation in CRC cells PMC6399964
LOVO cells 2 μM MHY1485 was used as an autophagy inhibitor to study the role of FAT4 in autophagy regulation in CRC cells PMC6399964
SW480 cells 2 μM MHY1485 was used as an autophagy inhibitor to study the role of FAT4 in autophagy regulation in CRC cells PMC6399964
LIU-LSC-1 cells 10 µM 24 h To evaluate the effect of MHY1485 on ITGA5 expression in LIU-LSC-1 cells, the results showed that MHY1485 significantly upregulated ITGA5 expression. PMC9691358
TU177 cells 10 µM 24 h To evaluate the effect of MHY1485 on ITGA5 expression in TU177 cells, the results showed that MHY1485 significantly upregulated ITGA5 expression. PMC9691358
Human Umbilical Vein Endothelial Cells (HUVECs) 100 nM 48 h Validated the effect of FOXC1 knockdown on the expression of SLC3A2 and SLC7A5 through siRNA. PMC11099035

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
SD rats Osteoarthritis model Intra-articular injection 0.3 mg Twice a week for 5 weeks MHY1485 inhibited autophagy, offsetting the anti-inflammatory effects of moderate-intensity exercise, resulting in more severe osteoarthritis symptoms PMC8580998
mice ICR mice intraperitoneal injection 10 mg/kg 2 days MHY1485 blocked the autophagy signaling induced by FSH and maintained high levels of p-mTOR and p-S6K1 expression. PMC5596559
Mice EC-Foxc1-KO mice Intraperitoneal injection 0.01 mg/g Once daily for 2 days Partially rescued the retinal angiogenesis defect in EC-Foxc1-KO mice by stimulating the mTOR signaling pathway. PMC11099035

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.58mL

0.52mL

0.26mL

12.91mL

2.58mL

1.29mL

25.81mL

5.16mL

2.58mL

 

Historical Records

Categories